RXO (NYSE:RXO) Raised to “Neutral” at JPMorgan Chase & Co.

RXO (NYSE:RXO – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research note issued on Tuesday, Benzinga reports. The firm presently has a $30.00 target price on the stock, up from their previous target price of $22.00. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 5.65% from the company’s previous close.

A number of other analysts have also issued reports on RXO. Citizens Jmp raised shares of RXO from a “market perform” rating to an “outperform” rating and set a $30.00 price target for the company in a research report on Friday, August 7th. Stifel Nicolaus set a $31.00 price objective on shares of RXO in a research report on Friday, August 7th. Wells Fargo & Company reiterated a “positive” rating on shares of RXO in a research note on Thursday, September 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of RXO in a research report on Tuesday, September 1st. Finally, UBS Group set a $19.00 target price on shares of RXO in a research note on Wednesday, September 23rd. Four investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $26.08.

Get Our Latest Research Report on RXO

RXO Trading Down 0.5%

RXO stock opened at $28.39 on Tuesday. RXO has a 52 week low of $10.43 and a 52 week high of $29.90. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.27 and a current ratio of 1.27. The firm has a market capitalization of $4.68 billion, a price-to-earnings ratio of -46.55 and a beta of 2.10. The company has a 50 day moving average price of $21.41 and a 200 day moving average price of $22.14.

RXO (NYSE:RXO – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. RXO had a negative net margin of 1.72% and a negative return on equity of 0.98%. The company had revenue of $1.77 billion for the quarter, compared to the consensus estimate of $1.63 billion. During the same period in the previous year, the business earned $0.04 EPS. The company’s revenue was up 25.0% on a year-over-year basis. Research analysts forecast that RXO will post 0.14 EPS for the current year.

Institutional Investors Weigh In On RXO

Several hedge funds have recently modified their holdings of RXO. Maple Rock Capital Partners Inc. acquired a new position in RXO during the 2nd quarter valued at $71,283,000. Dimensional Fund Advisors LP grew its position in RXO by 32.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,048,903 shares of the company’s stock worth $29,949,000 after purchasing an additional 504,955 shares during the last quarter. Principal Financial Group Inc. grew its position in RXO by 2.0% in the 1st quarter. Principal Financial Group Inc. now owns 798,285 shares of the company’s stock worth $11,671,000 after purchasing an additional 16,029 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of RXO by 128.6% during the 1st quarter. Bank of America Corp DE now owns 724,060 shares of the company’s stock worth $10,586,000 after purchasing an additional 407,285 shares during the period. Finally, Kennedy Capital Management LLC bought a new position in shares of RXO during the 4th quarter worth about $9,098,000. 92.73% of the stock is owned by institutional investors.

More RXO News

Here are the key news stories impacting RXO this week:

  • Positive Sentiment: C.H. Robinson’s proposed $5.8 billion acquisition gives RXO shareholders a clear transaction-related valuation catalyst and would combine two major freight-brokerage platforms. Analysts say the deal could benefit from greater scale, network efficiencies and ongoing consolidation in the logistics industry. C.H. Robinson to Acquire RXO in $5.8B Logistics Deal
  • Positive Sentiment: TD Cowen upgraded RXO from Sell to Hold and raised its price target to $30.25, signaling that the acquisition has improved the risk-reward profile. TD Cowen Upgrades RXO to Hold From Sell
  • Neutral Sentiment: Analyst views are mixed following the announcement. JPMorgan upgraded RXO to Neutral and lifted its target to $30, while Jefferies moved from Buy to Hold with a $30 target. The targets suggest analysts see limited additional upside at the current valuation, despite the deal premium. Analysts see promise, risks in C.H. Robinson-RXO deal
  • Neutral Sentiment: Market commentary highlights potential benefits from freight-industry consolidation but also raises questions about integration, competition and whether the combined company can maintain service quality and supply-chain resilience for shippers. C.H. Robinson’s $5.8B RXO acquisition aims to lead freight consolidation
  • Negative Sentiment: An M&A law firm announced an investigation into the proposed sale, potentially adding legal and execution uncertainty. Such investigations are common in public-company acquisitions but could create delays or pressure the transaction terms if shareholder claims advance. Shareholder Alert: Investigation of RXO

RXO Company Profile

(Get Free Report)

RXO, Inc is a transportation services company that provides asset-light freight brokerage and logistics solutions. The company connects shippers with independent carriers and helps coordinate the movement of truckload, less-than-truckload and other freight across North America.

RXO’s services include digital freight brokerage, managed transportation and last-mile logistics. Its brokerage business uses technology and carrier relationships to match customer shipments with available transportation capacity, while its managed transportation offerings help companies plan, coordinate and optimize freight operations.

Further Reading

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.